fasudil has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 2 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, Y | 1 |
| Zhang, Q | 2 |
| Xi, J | 1 |
| Xiao, B | 1 |
| Li, Y | 1 |
| Ma, C | 1 |
| He, Q | 1 |
| Li, YH | 1 |
| Guo, SS | 1 |
| Wang, Y | 1 |
| Lin, W | 1 |
| Wang, J | 1 |
| Ma, CG | 1 |
| Xiao, BG | 1 |
2 other studies available for fasudil and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals | 2015 |
Inhibition of Rho-kinase by Fasudil protects dopamine neurons and attenuates inflammatory response in an intranasal lipopolysaccharide-mediated Parkinson's model.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Administration, Intranasal; alpha-Synuclein; Animals; | 2016 |